NASDAQ:OPK OPKO Health (OPK) Stock Forecast, Price & News $1.45 +0.05 (+3.57%) (As of 06/2/2023 ET) Add Compare Share Share Today's Range$1.40▼$1.4750-Day Range$1.32▼$1.8652-Week Range$1.00▼$3.07Volume3.10 million shsAverage Volume2.36 million shsMarket Capitalization$1.12 billionP/E RatioN/ADividend YieldN/APrice Target$4.13 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability OPKO Health MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside185.1% Upside$4.13 Price TargetShort InterestBearish9.82% of Float Sold ShortDividend StrengthN/ASustainability-1.65Upright™ Environmental ScoreNews Sentiment0.35Based on 3 Articles This WeekInsider TradingAcquiring Shares$1.78 M Bought Last QuarterProj. Earnings GrowthGrowingFrom ($0.28) to ($0.24) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.26 out of 5 starsMedical Sector231st out of 983 stocksPharmaceutical Preparations Industry104th out of 486 stocks 3.5 Analyst's Opinion Consensus RatingOPKO Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $4.13, OPKO Health has a forecasted upside of 185.1% from its current price of $1.45.Amount of Analyst CoverageOPKO Health has only been the subject of 1 research reports in the past 90 days. Previous Next 0.0 Short Interest Percentage of Shares Shorted9.82% of the float of OPKO Health has been sold short.Short Interest Ratio / Days to CoverOPKO Health has a short interest ratio ("days to cover") of 12.9, which indicates bearish sentiment.Change versus previous monthShort interest in OPKO Health has recently increased by 1.87%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldOPKO Health does not currently pay a dividend.Dividend GrowthOPKO Health does not have a long track record of dividend growth. Previous Next 4.4 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreOPKO Health has received a 66.30% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Calcifediol", "Diagnostic test kits", and "Clinical research services for physical health" products. See details.Environmental SustainabilityThe Environmental Impact score for OPKO Health is -1.65. Previous Next 1.9 News and Social Media Coverage News SentimentOPKO Health has a news sentiment score of 0.35. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for OPKO Health this week, compared to 3 articles on an average week.Search Interest27 people have searched for OPK on MarketBeat in the last 30 days. This is an increase of 13% compared to the previous 30 days.MarketBeat FollowsOnly 5 people have added OPKO Health to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, OPKO Health insiders have bought more of their company's stock than they have sold. Specifically, they have bought $1,783,570.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders40.97% of the stock of OPKO Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 23.49% of the stock of OPKO Health is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for OPKO Health are expected to grow in the coming year, from ($0.28) to ($0.24) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of OPKO Health is -3.82, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of OPKO Health is -3.82, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioOPKO Health has a P/B Ratio of 0.72. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About OPKO Health (NASDAQ:OPK) StockOPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment includes the clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.Read More Receive OPK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for OPKO Health and its competitors with MarketBeat's FREE daily newsletter. Email Address OPK Stock News HeadlinesJune 2, 2023 | finance.yahoo.comWhy Is OPKO Health (OPK) Down 17.2% Since Last Earnings Report?June 1, 2023 | thestreet.com'Mad Money' Lightning Round: Stick With Opko HealthJune 4, 2023 | Legacy Research (Affiliate) (Ad)“One-Stock Millionaire” IGNORES 99.9% of the MarketDuring the 2008 financial crisis, millionaire trader Jeff Clark stunned the world when he managed to double his readers’ money 26 TIMES… CNBC caught wind of this and asked Jeff to come on live TV to explain his secret.May 31, 2023 | americanbankingnews.comOPKO Health (NASDAQ:OPK) Upgraded to "Hold" by StockNews.comMay 24, 2023 | benzinga.comCarrier Screening Global Market Report 2023: Increase in Fetal Chromosomal Abnormalities Drives GrowthMay 23, 2023 | msn.comFactbox: Weight-loss drugs: the next gold rushMay 23, 2023 | markets.businessinsider.comNona Biosciences Enters into Antibody Discovery Agreement with OPKO Health's ModeX TherapeuticsMay 12, 2023 | reuters.comFactbox: Drugmakers bulk up with bets on weight-loss treatmentsJune 4, 2023 | Legacy Research (Affiliate) (Ad)“One-Stock Millionaire” IGNORES 99.9% of the MarketDuring the 2008 financial crisis, millionaire trader Jeff Clark stunned the world when he managed to double his readers’ money 26 TIMES… CNBC caught wind of this and asked Jeff to come on live TV to explain his secret.May 11, 2023 | msn.comOPKO Health's Future After Merck Deal: Bright Or UncertainMay 10, 2023 | finance.yahoo.comGary Nabel Spends US$541k On OPKO Health Stock \May 10, 2023 | seekingalpha.comOPKO Health: There Could Be A Chance For UpsideMay 10, 2023 | americanbankingnews.comBarrington Research Equities Analysts Decrease Earnings Estimates for OPKO Health, Inc. (NASDAQ:OPK)May 9, 2023 | msn.comOPKO Health And 2 Other Penny Stocks Insiders Are Aggressively BuyingMay 9, 2023 | marketwatch.comMonday 5/8 Insider Buying Report: OPK, ZIONMay 9, 2023 | americanbankingnews.comHC Wainwright Weighs in on OPKO Health, Inc.'s Q1 2024 Earnings (NASDAQ:OPK)May 8, 2023 | americanbankingnews.comOPKO Health, Inc. (NASDAQ:OPK) Insider Purchases $339,570.48 in StockMay 7, 2023 | americanbankingnews.comOPKO Health (NASDAQ:OPK) Price Target Cut to $5.40May 7, 2023 | americanbankingnews.comResearch Analysts Offer Predictions for OPKO Health, Inc.'s Q1 2024 Earnings (NASDAQ:OPK)May 6, 2023 | americanbankingnews.comOPKO Health (NASDAQ:OPK) Shares Up 8.5% on Strong EarningsMay 5, 2023 | marketwatch.comRare Disease Genetic Testing Market Financial Overview Report 2023May 5, 2023 | markets.businessinsider.comBarrington Reaffirms Their Hold Rating on Opko Health (OPK)May 5, 2023 | msn.comHC Wainwright & Co. Reiterates Opko Health (OPK) Buy RecommendationMay 4, 2023 | msn.comOPKO Health (OPK) Q1 Earnings and Revenues Top EstimatesMay 4, 2023 | reuters.comNovo Nordisk rivals see room to compete in $100 bln weight-loss drug marketMay 4, 2023 | finance.yahoo.comQ1 2023 OPKO Health Inc Earnings CallMay 3, 2023 | msn.comRecap: OPKO Health Q1 EarningsSee More Headlines OPK Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OPK Company Calendar Last Earnings5/03/2023Today6/04/2023Next Earnings (Estimated)8/03/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Pharmaceutical preparations Sub-IndustryBiotechnology SectorMedical Current SymbolNASDAQ:OPK CUSIP68375N10 CIK944809 Webwww.opko.com Phone(305) 575-4100Fax305-575-6015Employees4,196Year FoundedN/APrice Target and Rating Average Stock Price Forecast$4.13 High Stock Price Forecast$5.40 Low Stock Price Forecast$3.00 Forecasted Upside/Downside+185.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.38) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-328,400,000.00 Net Margins-31.92% Pretax Margin-36.37% Return on Equity-13.63% Return on Assets-9.86% Debt Debt-to-Equity Ratio0.14 Current Ratio1.83 Quick Ratio1.49 Sales & Book Value Annual Sales$912.55 million Price / Sales1.23 Cash FlowN/A Price / Cash FlowN/A Book Value$2.01 per share Price / Book0.72Miscellaneous Outstanding Shares772,651,000Free Float456,096,000Market Cap$1.12 billion OptionableOptionable Beta1.66 Key ExecutivesPhillip FrostChairman & Chief Executive OfficerElias A. ZerhouniVice Chairman & PresidentAdam E. LogalCFO, Treasurer, Chief Accounting Officer & SVPJane H. HsaioVice Chairman & Chief Technical OfficerSteven D. RubinDirector & Executive Vice President-AdministrationKey CompetitorsMannKindNASDAQ:MNKDLigand PharmaceuticalsNASDAQ:LGNDInnovivaNASDAQ:INVADynavax TechnologiesNASDAQ:DVAXLexicon PharmaceuticalsNASDAQ:LXRXView All CompetitorsInsiders & InstitutionsAmeriprise Financial Inc.Sold 8,000 shares on 5/22/2023Ownership: 0.014%JPMorgan Chase & Co.Sold 10,918 shares on 5/18/2023Ownership: 0.164%New York State Common Retirement FundSold 65,300 shares on 5/18/2023Ownership: 0.025%Susquehanna International Group LLPBought 2,400 shares on 5/16/2023Ownership: 0.000%HBK Sorce Advisory LLCBought 20,056 shares on 5/16/2023Ownership: 0.003%View All Insider TransactionsView All Institutional Transactions OPK Stock - Frequently Asked Questions Should I buy or sell OPKO Health stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for OPKO Health in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" OPK shares. View OPK analyst ratings or view top-rated stocks. What is OPKO Health's stock price forecast for 2023? 2 analysts have issued 1-year price objectives for OPKO Health's shares. Their OPK share price forecasts range from $3.00 to $5.40. On average, they predict the company's stock price to reach $4.13 in the next year. This suggests a possible upside of 185.1% from the stock's current price. View analysts price targets for OPK or view top-rated stocks among Wall Street analysts. How have OPK shares performed in 2023? OPKO Health's stock was trading at $1.25 at the beginning of 2023. Since then, OPK shares have increased by 16.0% and is now trading at $1.45. View the best growth stocks for 2023 here. When is OPKO Health's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023. View our OPK earnings forecast. How were OPKO Health's earnings last quarter? OPKO Health, Inc. (NASDAQ:OPK) issued its quarterly earnings data on Wednesday, May, 3rd. The biotechnology company reported ($0.02) EPS for the quarter, topping analysts' consensus estimates of ($0.07) by $0.05. The biotechnology company earned $237.60 million during the quarter, compared to analysts' expectations of $193.35 million. OPKO Health had a negative net margin of 31.92% and a negative trailing twelve-month return on equity of 13.63%. The company's revenue for the quarter was down 27.8% on a year-over-year basis. During the same period in the prior year, the business earned ($0.08) earnings per share. What ETFs hold OPKO Health's stock? ETFs with the largest weight of OPKO Health (NASDAQ:OPK) stock in their portfolio include ETFMG Treatments Testing and Advancements ETF (GERM), ALPS Medical Breakthroughs ETF (SBIO), Invesco Nasdaq Future Gen 200 ETF (QQQS), SPDR S&P Health Care Services ETF (XHS), VanEck Israel ETF (ISRA), iShares U.S. Healthcare Providers ETF (IHF), iShares Biotechnology ETF (IBB) and What is Philip Frost's approval rating as OPKO Health's CEO? 21 employees have rated OPKO Health Chief Executive Officer Philip Frost on Glassdoor.com. Philip Frost has an approval rating of 16% among the company's employees. This puts Philip Frost in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of OPKO Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other OPKO Health investors own include TherapeuticsMD (TXMD), Micron Technology (MU), NVIDIA (NVDA), bluebird bio (BLUE), Gilead Sciences (GILD), Pfizer (PFE), Inovio Pharmaceuticals (INO), Novavax (NVAX), Advanced Micro Devices (AMD) and AT&T (T). What is OPKO Health's stock symbol? OPKO Health trades on the NASDAQ under the ticker symbol "OPK." Who are OPKO Health's major shareholders? OPKO Health's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (4.53%), State Street Corp (1.36%), Geode Capital Management LLC (1.09%), Dimensional Fund Advisors LP (0.89%), Charles Schwab Investment Management Inc. (0.63%) and Numerai GP LLC (0.29%). Insiders that own company stock include Elias A Zerhouni, Gary J Nabel, Jon R Cohen, Opko Health, Inc, Phillip Md Et Al Frost, Robert J Shovlin and Steven D Rubin. View institutional ownership trends. How do I buy shares of OPKO Health? Shares of OPK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is OPKO Health's stock price today? One share of OPK stock can currently be purchased for approximately $1.45. How much money does OPKO Health make? OPKO Health (NASDAQ:OPK) has a market capitalization of $1.12 billion and generates $912.55 million in revenue each year. The biotechnology company earns $-328,400,000.00 in net income (profit) each year or ($0.38) on an earnings per share basis. How many employees does OPKO Health have? The company employs 4,196 workers across the globe. How can I contact OPKO Health? OPKO Health's mailing address is 4400 BISCAYNE BLVD., MIAMI FL, 33137. The official website for the company is www.opko.com. The biotechnology company can be reached via phone at (305) 575-4100, via email at mmiller@lhai.com, or via fax at 305-575-6015. This page (NASDAQ:OPK) was last updated on 6/4/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OPKO Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.